Use Of OdonAssist Device Tied To Higher Rate Of Successful Assisted Vaginal Deliveries, Finds Study
- byDoctor News Daily Team
- 13 July, 2025
- 0 Comments
- 0 Mins
Recent research paper "Safety and efficacy of the OdonAssist inflatable device for assisted vaginal birth: the BESANCON ASSIST study" aimed to investigate the safety and efficacy of the OdonAssist inflatable device before conducting a randomized controlled trial. The study was an open-label, nonrandomized investigation of 104 women with clinically indicated assisted vaginal delivery using the OdonAssist at the Besancon University Hospital, France. The primary outcome measure was the proportion of successful assisted vaginal births using the OdonAssist, and the secondary outcomes included neonatal and maternal data, ease of use of the device, and maternal perception ratings of the birth experience.
Safety and Efficacy Results
The study reported a success rate of 88.5% for assisted vaginal births using the OdonAssist, with no emergency cesarean deliveries performed in the OdonAssist group, and no serious adverse maternal or neonatal reactions related to the use of the device. The rate of third- and fourth-degree perineal tears with the OdonAssist was 3.8%, and maternal perception ratings of the birth experience with the OdonAssist were high. The paper also highlighted the safety and efficacy of the OdonAssist as an alternative to other current devices for assisted vaginal births, with high acceptance rates among pregnant women and the high rate of successful assisted vaginal births using the OdonAssist confirming the feasibility of a future randomized controlled trial.
Design and Innovation
The study used an innovative design combining mechanical principles that favor the progression of the fetal head, including propulsion, flexion, and traction. The device was reported to be safer, easier to use, and more acceptable to women and obstetricians than currently available instruments. The success rate was higher than previously reported in a feasibility study, and the results confirmed the feasibility of conducting randomized controlled trials to evaluate the efficacy of OdonAssist in comparison with other assisted vaginal delivery devices.
Conclusion
Overall, the study concluded that the OdonAssist is a safe and effective alternative to other current devices for assisted vaginal births, with the high acceptance rate among pregnant women and the high rate of successful assisted vaginal births using the OdonAssist confirming the feasibility of a future randomized controlled trial. The detailed findings and safety and efficacy data from this study contribute to the existing knowledge on the OdonAssist device and support the feasibility of future randomized controlled trials to further evaluate its performance and safety in comparison with other assisted vaginal delivery devices.
Key Points
1. The study aimed to investigate the safety and efficacy of the OdonAssist inflatable device for assisted vaginal birth before conducting a randomized controlled trial.
2. Safety and efficacy results revealed a success rate of 88.5% for assisted vaginal births using the OdonAssist, with no emergency cesarean deliveries performed in the OdonAssist group and no serious adverse maternal or neonatal reactions related to the use of the device. The rate of third- and fourth-degree perineal tears with the OdonAssist was 3.8%, and maternal perception ratings of the birth experience with the OdonAssist were high.
3. The study used an innovative design combining mechanical principles favoring fetal head progression, including propulsion, flexion, and traction. The OdonAssist was reported to be safer, easier to use, and more acceptable to women and obstetricians than currently available instruments. The high success rate confirmed the feasibility of conducting randomized controlled trials to evaluate the efficacy of OdonAssist in comparison with other assisted vaginal delivery devices.
4. The OdonAssist was highlighted as a safe and effective alternative to other current devices for assisted vaginal births, with high acceptance rates among pregnant women. The detailed findings and safety and efficacy data from this study contribute to the existing knowledge on the OdonAssist device, supporting the feasibility of future randomized controlled trials to further evaluate its performance and safety in comparison with other assisted vaginal delivery devices.
5. The primary outcome measure was the proportion of successful assisted vaginal births using the OdonAssist, and the secondary outcomes included neonatal and maternal data, ease of use of the device, and maternal perception ratings of the birth experience.
6. Overall, the study concluded that the OdonAssist is a safe and effective alternative to other current devices for assisted vaginal births, with the high acceptance rate among pregnant women and the high rate of successful assisted vaginal births using the OdonAssist confirming the feasibility of a future randomized controlled trial.
Reference
Mottet N, Hotton E, Eckman-Lacroix A, Bourtembourg A, Metz JP, Cot S, Poitrey E, Delhomme L, Languerrand E, Nallet C, Lallemant M, Draycott T, Riethmuller D. Safety and efficacy of the OdonAssist inflatable device for assisted vaginal birth: the BESANCON ASSIST study. Am J Obstet Gynecol. 2024 Mar;230(3S):S947-S958. doi: 10.1016/j.ajog.2023.05.016. Epub 2023 Aug 1. PMID: 38462265.
Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at
admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our
Terms of Use,
Privacy Policy, and
Advertisement Policy.
For further details, please review our
Full Disclaimer.
Recent News
DME Gujarat extends PG Ayurveda, Homeopathy round...
- 05 November, 2025
NEET counselling: CENTAC publishes round 3 provisi...
- 05 November, 2025
Marksans Pharma UK arm gets marketing nod for Exem...
- 05 November, 2025
Zydus Wellness net sales up by 31 percent in Q2 FY...
- 05 November, 2025
Daily Newsletter
Get all the top stories from Blogs to keep track.
0 Comments
Post a comment
No comments yet. Be the first to comment!